- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Potentially Resectable ALK Positive Non-Small Cell Lung Cancer in United States
Total 4372 results
-
M.D. Anderson Cancer CenterNot yet recruitingNon-small Cell Lung CancerUnited States
-
University of TennesseeCellSight Technologies, Inc.RecruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalGenentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonCompletedNon Small Cell Lung CancerUnited States
-
Massachusetts General HospitalCompleted
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedNon-small Cell Lung CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminated
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
Providence Health & ServicesNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedNon Small Cell Lung CancerUnited States
-
Milton S. Hershey Medical CenterTerminatedNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)TerminatedNon-small Cell Lung CancerUnited States
-
Heat BiologicsWithdrawnNon-small Cell Lung CancerUnited States
-
Sun Farm CorporationNational Center for Complementary and Integrative Health (NCCIH)UnknownNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsCompletedNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteRecruitingSmall Cell Lung Carcinoma | Non Small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Ohio State University Comprehensive Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small...United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Extensive Stage Small Cell Lung Carcinoma | Squamous Cell Lung Carcinoma | Recurrent Small Cell Lung CarcinomaUnited States
-
Aetion, Inc.CompletedMetastatic Lung Cancer | Non-small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Susanne ArnoldKentucky Lung Cancer Research ProgramCompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
CellSight Technologies, Inc.University of Iowa Hospitals & ClinicsNot yet recruiting
-
Muhammad FurqanRecruitingNon-small Cell Lung CancerUnited States
-
State University of New York - Upstate Medical...RecruitingNon-small Cell Lung CancerUnited States
-
Albert Einstein College of MedicineCompletedNon-small Cell Lung CancerUnited States
-
Sue YomMerck Sharp & Dohme LLCCompletedNon Small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedNon-small Cell Lung CancerUnited States
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
Duke UniversityCompleted
-
Leo W. Jenkins Cancer CenterEast Carolina UniversityTerminated
-
West Virginia UniversityCelgene CorporationWithdrawnNon-small Cell Lung CancerUnited States
-
Providence Health & ServicesBristol-Myers Squibb; Genentech, Inc.TerminatedNon-squamous Non-small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | EGFR Activating Mutation | Stage IV Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Translocation | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | ROS1 Gene TranslocationUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
NewLink Genetics CorporationTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Recurrent | Progression of Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | EGFR Gene Mutation | Unresectable Lung Non-Small... and other conditionsUnited States
-
Alliance Foundation Trials, LLC.AstraZenecaActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung CancerUnited States
-
PfizerMerck Sharp & Dohme LLCTerminatedALK-positive Advanced NSCLCUnited States
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia
-
Worldwide Innovative Network AssociationPfizer; ARC Foundation for Cancer ResearchTerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBIsrael, United States, Luxembourg, Spain
-
National Cancer Institute (NCI)TerminatedStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States
-
National Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
Duke UniversityBristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)RecruitingNon Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States, Canada